Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Abroad (travel likely)RecruitingPHASE2

Conditions

Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium
Contact: Study coordinator (Cisse Geleyn, dr.) · cisse.geleyn@uzgent.be · +3293328742
Contact: Study coordinator (Gilbert Lemmens, prof. dr.)

Study leads

Gilbert Lemmens, Prof. dr.
Principal Investigator
University Hospital, Ghent

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Treatment Resistant Depression · Chronic Pain

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

Treatment Resistant Depression

IsraelRecruitingPHASE2

Beersheba, Israel

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE2

Liverpool, United Kingdom · London, United Kingdom

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Major Depressive Disorder · Suicide · Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada